MF59-adjuvanted trivalent seasonal influenza vaccine compared to high-dose trivalent seasonal influenza vaccine among older adults, a systematic literature review

被引:0
|
作者
Dang, J. [1 ]
McGovern, I. [1 ]
Haag, M. [1 ]
Coleman, B. [2 ]
机构
[1] CSL Seqirus, Summit, NJ USA
[2] Univ Toronto, Publ Hlth, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
A81
引用
收藏
页码:S42 / S43
页数:2
相关论文
共 50 条
  • [21] Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017-2020 influenza seasons
    McGovern, Ian
    Chastek, Benjamin
    Bancroft, Tim
    Webb, Noah
    Imran, Mahrukh
    Pelton, Stephen I.
    Haag, Mendel D. M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 146
  • [22] Letter to editor regarding the systematic review and meta-analysis by Coleman et al. on the effectiveness of MF59-adjuvanted seasonal influenza vaccine in older adults
    Yin, J. Kevin
    Samson, Sandrine I.
    Nealon, Joshua
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (06) : 826 - 827
  • [23] Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
    De Donato, S
    Granoff, D
    Minutello, M
    Lecchi, G
    Faccini, M
    Agnello, M
    Senatore, F
    Verweij, P
    Fritzell, B
    Podda, A
    VACCINE, 1999, 17 (23-24) : 3094 - 3101
  • [24] Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
    Villa, Marco
    Black, Steven
    Groth, Nicola
    Rothman, Kenneth J.
    Apolone, Giovanni
    Weiss, Noel S.
    Aquino, Ivana
    Boldori, Liana
    Caramaschi, Fausta
    Gattinoni, Antonio
    Malchiodi, Giancarlo
    Crucitti, Antonio
    Della Cioppa, Giovanni
    Scarpini, Elio
    Mavilio, Domenico
    Mannino, Salvatore
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (07) : 1139 - 1145
  • [25] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    Gasparini, R
    Pozzi, T
    Montomoli, E
    Fragapane, E
    Senatore, F
    Minutello, M
    Podda, A
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (02) : 135 - 140
  • [26] The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
    Podda, A
    VACCINE, 2001, 19 (17-19) : 2673 - 2680
  • [27] Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence
    Loperto, Ilaria
    Simonetti, Andrea
    Nardone, Antonio
    Triassi, Maria
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1035 - 1047
  • [28] Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine
    Song, Joon Young
    Cheong, Hee Jin
    Noh, Ji Yun
    Seo, Yu Bin
    Choi, Won Suk
    Cho, Geum Joo
    Hwang, Taik Gun
    Kim, Woo Joo
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (09) : 1591 - 1597
  • [29] Recombinant Trivalent Influenza Vaccine (Flublok®): A Review of Its Use in the Prevention of Seasonal Influenza in Adults
    Yang, Lily P. H.
    DRUGS, 2013, 73 (12) : 1357 - 1366
  • [30] Recombinant Trivalent Influenza Vaccine (Flublok®): A Review of Its Use in the Prevention of Seasonal Influenza in Adults
    Lily P. H. Yang
    Drugs, 2013, 73 : 1357 - 1366